TOP STORIES
Woodford-backed Perceptive Bioscience officially launched today. It’s a new global evergreen bioscience fund focused on everything from seed-stage companies to “mispriced public companies with products in late-stage development.” – Perceptive Bioscience
HIMSS is imminent: Here’s HISTalk’s always reliable guide to HIMSS. – HISTalk
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
China’s IMPACT Therapeutics, focused on oncology, landed another $10 million to drive clinical studies and its pipeline. IMPACT is backed by Lilly Asia Ventures and Wuxi AppTec Ventures, among others. – PRNewswire
Europe has approved Bayer’s hemophilia A drug Kovaltry for all age groups. – Reuters
Hospitech Respiration received FDA 510(k) pre-market clearance for its airway management product, AnapnoGuard 100 System1. – Business Wire
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The bioanalytical testing service BioAgilytix has purchased IPM Biotech, a German contract research laboratory focused on large molecule bioanalysis. – Business Wire
Antibiotic resistance in China: It’s in the water. – Reuters
PAYERS-PROVIDERS
Public redemption for the HPV vaccine? It’s already reduced the virus’ prevalence in teenage girls by almost two-thirds. – The New York Times
TECHNOLOGY
Akili Interactive Labs gets a nice mention in this overview about pharma’s attempts to integrate video games into its treatments. – Financial Times
Here’s how the Apple privacy fight trickles back into healthcare. – The Health Care Blog
POLITICS
Dr. Robert Califf’s slow slog to lead the FDA will get a push this week. Who gets appointed first: FDA chief or an Antonin Scalia replacement on the Supreme Court? – STAT
Why “network adequacy” statutes matter – and here’s how healthcare interests are pushing to change them to make health insurance companies continue to pay for certain levels of medical care. – Forbes
LITTLE BIT EXTRA
Always. Watch. Facebook. Take a look at its “Telecom Infra Project,” which is trying to the redesign telecommunications infrastructure, and take a deeper look at how Facebook is continuing to push virtual reality into the mainstream. – Business Insider and WIRED
Photo: Flickr user zzzack
